Head to Head Comparison: C.P. Pokphand (OTCMKTS:CPKPY) and MDxHealth (OTCMKTS:MXDHF)

C.P. Pokphand (OTCMKTS:CPKPY) and MDxHealth (OTCMKTS:MXDHF) are both consumer staples companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, profitability, dividends, risk, valuation, earnings and institutional ownership.

Earnings & Valuation

This table compares C.P. Pokphand and MDxHealth”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
C.P. Pokphand	$4.33 billion	0.82	$2.16 billion	N/A	N/A
MDxHealth	$37.05 million	0.00	-$44.04 million	N/A	N/A

C.P. Pokphand has higher revenue and earnings than MDxHealth.

Analyst Ratings

This is a breakdown of current recommendations and price targets for C.P. Pokphand and MDxHealth, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
C.P. Pokphand	0	0	0	0	0.00
MDxHealth	0	0	1	0	3.00

Given MDxHealth’s stronger consensus rating and higher probable upside, analysts clearly believe MDxHealth is more favorable than C.P. Pokphand.

Institutional & Insider Ownership

0.0% of C.P. Pokphand shares are held by institutional investors. 1.7% of MDxHealth shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Risk and Volatility

C.P. Pokphand has a beta of 0.42, meaning that its stock price is 58% less volatile than the S&P 500. Comparatively, MDxHealth has a beta of 1.46, meaning that its stock price is 46% more volatile than the S&P 500.

Profitability

This table compares C.P. Pokphand and MDxHealth’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
C.P. Pokphand	N/A	N/A	N/A
MDxHealth	N/A	N/A	N/A

Summary

MDxHealth beats C.P. Pokphand on 5 of the 8 factors compared between the two stocks.

About C.P. Pokphand

CP Pokphand Co. Ltd. is an investment holding company, which engages in the manufacture and trade of animal feed products. It operates through the following business segments: China Agri-Food; Vietnam Agri-Food; and Investment and Property Holding. The China Agri-Food segment produces and distributes animal feed and processed food. The Vietnam Agri-Food segment breeds, farms, and sells livestock and aquatic animals. The Investment and Property Holding segment manages and leases out residential and commercial projects. The company was founded in 1987 and is headquartered in Hong Kong.

About MDxHealth

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.